leadf
logo-loader
TSX:MDG

Medicago

Receive alerts
Market:
TSX
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The Company is committed to providing highly effective and competitive vaccines and therapeutic proteins based on its proprietary Virus-Like Particles (VLPs) and manufacturing technologies. Medicago is a worldwide leader in the development of VLP vaccines using a transient expression system which produces recombinant vaccine antigens in plants.